DR VIJAY BADE.ADOLESCENT MEDICINE PH 9881398048 Email drbvb111@gmail.com iNCOVACC Is a nasal vaccine indicated for active immunization against SARS-CoV-2 virus infection. AGE FOR VACCINATION age ≥18 years. • The nasal route has excellent potential for vaccination due to the organized immune systems of the nasal mucosa. • Non-invasive, Needle-free. • Ease of administration – does not require trained health care workers. • Elimination of needle-associated risks (injuries and infections). • High compliance. • Scalable manufacturing – able to meet global demand. • ROUTE INCOVACC® is administered through the nose, as a 2-dose series, 4 weeks apart. A total of 8 drops (0.5 mL per dose), 4 drops are administered into each nostril. • Side effects Headache • Fever • Running nose • Sneezing Single booster dose to individuals aged 18 years and above, at ≥6 months after completion of primary schedule of Covishield or Covaxin® CONTRAINDICATION you should not get iNCOVACC® if you: • Had a se